Pfizer Stock Has 29% Upside, Says a New Bull
Guggenheim analysts initiated coverage of drug firm Pfizer at Buy with a $36 price target. Shares have lagged behind the market in recent years.
Source: marketwatch.com
Courtesy Pfizer News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Courtesy Pfizer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Courtesy Pfizer Today - Breaking & Trending Today
Pfizer Stock Dives. Its New Guidance Is Disappointing the Market.
Pfizer stock was falling early Wednesday after the pharmaceutical company revised its guidance for 2024.
Source: marketwatch.com
Pfizer Stock Falls to 10-Year Low on Guidance Slash. Why Wall Street Is Disappointed.
Pfizer stock was trading at a 10-year low on Wednesday after the pharmaceutical company revised its 2024 guidance. Its new earnings and revenue projections...
Source: marketwatch.com
Pfizer's Weight Loss Drug Won't Enter a Phase 3 Trial. The Stock Drops.
'We believe an improved once-daily formulation of danuglipron could play an important role in the obesity treatment paradigm,' Pfizer says
Source: marketwatch.com
Data on Pfizer's New Weight Loss Pill Is Coming. Why it's Crucial for the Stock.
Pfizer needs some of the obesity drug enthusiasm that's lifted Eli Lilly and Novo Nordisk stock.
Source: marketwatch.com